Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

158 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-11

Study Completion Date

2018-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to describe an immune activation profile of people at risk of insulin resistance based on a wide range of markers which will allow easy identification of patients at risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characterization of Type 2 Diabetes Subgroups at Diagnosis: a Necessary Step Towards Precision Medicine in Diabetes.

NCT05333718

Characteristics Disease Type 2 Diabetes

RECRUITING

Subjects With T2D or at Risk of T2D Cohort Follow-up

NCT05567692

Diabetes Mellitus, Type 2

ACTIVE_NOT_RECRUITING

Study of Diabetes' Risk Factors and Accelerated Aging According to Socio-economic Status in a Population From the North of France

NCT05717491

Diabetes PreDiabetes

COMPLETED

Insulin Resistance in Relation to Hyperthyroidism and Hypothyroidism

NCT06399796

Insulin Resistance

NOT_YET_RECRUITING

Relation of White Blood Cell Function to Diabetes

NCT00570154

Diabetes

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insulin Resistance Metabolic Syndrome X

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients aged 55-60

Blood test

Intervention Type OTHER

6ml blood sample taken

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood test

6ml blood sample taken

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient has been informed of the study, its objectives, constraints and the patient rights
* The patient must have given their free and informed consent and signed the consent form
* The patient is aged 55-69

Exclusion Criteria

* The subject is participating in an interventional category 1 study
* The patient has participated in another category 1 interventional study in the last 3 months
* The patient is in a period of exclusion determined by a previous study
* The patient is under safeguard of justice or state guardianship
* The subject refuses to sign the consent
* The subject does not understand the information

Minimum Eligible Age

55 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes